XML 44 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Schedule of Stock Options Activity

A summary of the Company’s stock option activity, for the three months ended March 31, 2026, was as follows:

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Life (Years)

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding as of December 31, 2025

 

 

2,316,417

 

 

$

2.81

 

 

 

3.76

 

 

$

24,431

 

Exercised

 

 

(9,152

)

 

 

1.74

 

 

 

 

 

 

 

Outstanding as of March 31, 2026

 

 

2,307,265

 

 

$

2.82

 

 

 

3.51

 

 

$

24,067

 

Vested and exercisable as of March 31, 2026

 

 

2,307,265

 

 

$

2.82

 

 

 

3.51

 

 

$

24,067

 

Vested and expected to vest as of March 31, 2026

 

 

2,307,265

 

 

$

2.82

 

 

 

3.51

 

 

$

24,067

 

Schedule of Restricted Stock Activity

The following table summarizes the Company's RSU activity (excluding PBRSUs) for the three months ended March 31, 2026:

 

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value
per Share

 

Outstanding as of December 31, 2025

 

 

7,137,273

 

 

$

6.51

 

Granted

 

 

381,506

 

 

 

13.35

 

Released

 

 

(1,395,300

)

 

 

8.45

 

Forfeited

 

 

(25,024

)

 

 

5.52

 

Outstanding as of March 31, 2026

 

 

6,098,455

 

 

$

6.39

 

Schedule of Fair Value Weighted-Average Assumptions The Company estimated the fair value of the market-based PBRSUs award on the grant date using the Monte Carlo simulation model with the following assumptions:

 

 

 

 

Expected term (years)

 

0.5 - 4.7

 

Expected volatility

 

 

70.9

%

Risk-free interest rate

 

 

3.29

%

Dividend yield

 

 

0

%

Share price

 

$

5.10

 

 

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense by function was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Cost of revenue

 

$

231

 

 

$

31

 

Research and development expenses

 

 

3,998

 

 

 

2,977

 

General and administrative expenses

 

 

5,001

 

 

 

1,376

 

Sales and marketing expenses

 

 

135

 

 

 

180

 

Total

 

$

9,365

 

 

$

4,564